Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD

NCT04733989 is registered in ClinicalTrials.gov with GAP Innovations, PBC as lead sponsor.

NCT NCT04733989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04733989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD
Lead sponsor
GAP Innovations, PBC
Phase
Observational
Overall status
Completed
Start date
April 21, 2021
Completion date
November 11, 2022
Enrollment
1,002 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, alzheimer disease, early onset, memory disorders, memory impairment, memory loss, mild cognitive impairment